Member Info for Richob

I think the post by gmcc needs repeating because it is a better positioning than the Huff Post could ever be.

https://www.dailymail.co.uk/money/markets/article-9355529/SMALL-CAP-MOVERS-Avacta-leaps-test-detects-new-Covid-variant.html

If just 1% of the 1 million readers look at this and if just 1% of those have the nous to buy it is 100 more investors. Can't see it being only 1% twice but even at that level it is a big positive.

Add to that that it is 5 weeks on Monday since Mologic took on the CE marking, then we are increasingly closer to real lift off.

Never been happier with an investment.

Onwards Avacta.

This is extremely positive and the fact that it covers more than just covid indicates that the author has done some research.

Over one million people read that paper and it is likely to have an uplifting effect you would think.

Combine that with the Roche comments about PCR and our very near term anticipated news flow plus some potential II interest and we have a great start to the weekend.

Did someone mention a whisky? It must be five o'clock somewhere.

Onwards Avacta.

Blackrock have been selling out of NCYT.

Wonder where they have been buying instead?

Onwards Avacta.

Thought I'd try and find out the rough timescales for CE marking.

"On average, the CE marking process takes four to six weeks. It can also take longer or shorter depending on test results, whether the product still needs to be modified, and how quickly the technical documentation can be supplied. The CE marking process differs for every product."

So. Nothing that exact but a broad brush timescale that's fits in well with what AS has said.

It is five weeks this coming Monday since the Mologic RNS and that leaves Avacta two weeks of March for their own ISO audit (second part), all of which fits nicely with what we have been told.

Perhaps the derampers would like to put a value on that.

Onwards Avacta.

If I am understanding correctly, this is on Tuesday morning next week.

Given how recent the last (fantastic) Vox interview was, you have to wonder why there is one so close to it.

Guessing positively, it wouldn't be beyond belief that AS is expecting to announce something ahead of this new interview. That leaves today, tomorrow, Monday or Tuesday am. What could it be?

No doubt a long shortlist could be drawn up.

In the meantime, MMs are clearly after shares.

Hmmmm. They will need very heavy pliers and water treatment to get any of mine.

Onwards Avacta.

Agree, vissain.

A quick click on the share trades provides the general direction.

All the best.

After two great news items this week which have told us that affimers detect variants and another large company want us, we also have the following:

A strong sp
A quiet confidence
More anticipated news flow
BAMS
ISO audit result for Avacta
CE marking Mologic
CE transfer
Trading Update
Anything we may not have thought of as well
Some momentum ahead of news flow

It is nice, innit?

Onwards Avacta.

The conclusion is that it is needed.

Onwards Avacta.

Poirot. I don't think Daewoong are having any trouble with trials in Asia. Don't think affimers have yet been included but obviously they want to combine platforms for some reasons. Also looks like this trial is on hold for now, so time for us to get there with a therapy I believe.

All the best.

Onwards Avacta.

https://australianonlinenews.com.au/2021/03/09/avacta-signs-diagnostic-licensing-deal-with-biokit/

To affinity and beyond.

Onwards Avacta.

They have to transfer product, process and documentation. The latter is likely to include the CE mark, which Mologic are doing.

Onwards Avacta.

Was it Avacta that tested for the variants or Mologic?

As the lateral flow test is clearly mentioned, it could well be Mologic as they move through the CE process. If this is the case we could be a bit nearer than the end of March perhaps.

Either way, detecting the existing dominant strains with the capability of amending for others, we seem to be progressing rather well.

Onwards Avacta.

https://m.uk.investing.com/news/stock-market-news/avacta-group-confirms-rapid-antigen-test-detects-new-covid-strains-2318863

Detecting variants looks like the key factor going forward.

Onwards Avacta.

And the 1 trades, Timster.

Onwards Avacta.

.. apparently with Dr Susan Hopkins, who it would appear majors in disease outbreak and surveillance.

Onwards Avacta.

Some were shaken with the 197.5p UT.

Some were rattled by the 190p UT.

Time for the roll past the 200p mark as we consider the news flow across numerous fronts on the way.

Onwards Avacta.

Followed by a UT at 190p just now.

Onwards Avacta.

Think it was the UT. Actual sp 193.5p.

Happens a lot these days.

Onwards Avacta.

I prefer "uber", Timster and we could add consistent, helpful, researched and amusing (occasionally) for a fuller description !

Onwards Avacta.

There has actually been strong buying all day (click on share trades and keep going) but the sp has barely moved. No doubt more delayed buys to show again.

After the excellent "Glaxo list" you would think that any sellers might need an IQ test.

Just an opinion and I am not a seller if you hadn't guessed.

Onwards Avacta.